Multiple pathways can control SREBP-1 to regulate lipogenesis in HCC, such as hepatoma-derived growth factor (HDGF), apoptosis-antagonizing transcription factors (AATF), or acyl-CoA synthetases. The gene discussed is AATF; the disease is hepatocellular carcinoma.